Suspected herbal hepatotoxicity: The pharmacovigilance dilemma with disputed and obsolete evaluation methods

Regulatory Toxicology and Pharmacology

Volumn 64, Issue 2, 2012, Pages 343-344

  Teschke, Rolf ^a   Frenzel, Christian ^b   Schulze, Johannes ^c   Eickhoff, Axel ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSAL ATTRIBUTION; CLINICAL ASSESSMENT; DRUG SURVEILLANCE PROGRAM; HERB; HUMAN; LETTER; LIVER DISEASE; LIVER TOXICITY; PELARGONIUM; PELARGONIUM SIDOIDES; PREDICTIVE VALUE; PRIORITY JOURNAL; PUBLICATION; SENSITIVITY AND SPECIFICITY;

EID: 84868300131     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2012.06.010     Document Type: Letter

References (11)

1. Aronson, J.K., 2011. Adverse drug reactions: history, terminology, classification, causality, frequency, preventability. In: Talbot, J., Aronson, J.K. (Eds.), Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice, Sixth ed., John Wiley & Sons, Ltd. doi:10.1002/9780470975053.ch1.
2. Bénichou C., Danan G., Flahault A. Causality assessment of adverse reactions to drugs - II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J. Clin. Epidemiol. 1993, 46:1331-1336.
3. Danan G., Bénichou C. Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J. Clin. Epidemiol. 1993, 46:1323-1330.
4. DCGMA, 2011. Drug Commission of the German Medical Association (Arzneimittelkommission der Deutschen Ärzteschaft). Hepatitis in connection with Umckaloabo®. Deutsches Ärzteblatt 108, C1399-C1400 (Article in German).
5. EMA, 2007. Assessment of case reports connected to herbal medicinal products containing cimicifugae racemosae rhizoma (black cohosh, root). Issued May 8, 2007. Available at: (accessed 26.05.12). http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2010/02/WC500074167.pdf.
6. Teschke R., Wolff A. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate?. Regul. Toxicol. Pharmacol. 2011, 59:1-7.
7. Teschke R., Frenzel C., Schulze J., Eickhoff A. Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: was causality adequately ascertained?. Regul. Toxicol. Pharmacol. 2012, 63:1-9.
8. Teschke R., Frenzel C., Wolff A., Herzog J., Glass X., Schulze J., Eickhoff A. Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvements. Ann. Hepatol. 2012, 11:500-512.
9. Teschke R., Schmidt-Taenzer W., Wolff A. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver unspecific Naranjo scale precise enough to ascertain causality?. Pharmacoepidemiol. Drug Saf. 2011, 20:567-582.
10. Teschke R., Schwarzenboeck A., Hennermann K.H. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br. J. Clin. Pharmacol. 2008, 66:758-766.
11. WHO, 2000. World Health Organization. The use of the WHO-UMC system for standardised case causality assessment. WHO Collaboratoring Centre for International Drug Monitoring (Uppsala Monitoring Centre, UMC), Database. Available at: (accessed 26.05.12). http://who-umc.org/Graphics/24734.pdf.